Katherine E. Mues

1.7k total citations
43 papers, 925 citations indexed

About

Katherine E. Mues is a scholar working on Surgery, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Katherine E. Mues has authored 43 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 16 papers in Economics and Econometrics and 7 papers in Infectious Diseases. Recurrent topics in Katherine E. Mues's work include Lipoproteins and Cardiovascular Health (22 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Pharmaceutical Economics and Policy (10 papers). Katherine E. Mues is often cited by papers focused on Lipoproteins and Cardiovascular Health (22 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Pharmaceutical Economics and Policy (10 papers). Katherine E. Mues collaborates with scholars based in United States, Australia and Canada. Katherine E. Mues's co-authors include Stephanie L. Mayne, Crista Johnson, Robert S. Rosenson, Paul Muntner, Rebecca Zaha, Keri L. Monda, Alexander Liede, Lisandro D. Colantonio, A. Bernard Collins and Jiannong Liu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Katherine E. Mues

42 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine E. Mues United States	15	345	216	193	188	145	43	925
M. Sanni Ali United Kingdom	19	188 0.5×	148 0.7×	207 1.1×	193 1.0×	82 0.6×	45	1.2k
Francesc Fina Spain	15	167 0.5×	189 0.9×	122 0.6×	296 1.6×	155 1.1×	35	1.1k
Myrick C. Shinall United States	17	327 0.9×	133 0.6×	80 0.4×	94 0.5×	177 1.2×	55	881
Jordan K. Rosedahl United States	16	153 0.4×	115 0.5×	79 0.4×	208 1.1×	95 0.7×	35	803
Alinda G. Vos Netherlands	14	178 0.5×	177 0.8×	121 0.6×	195 1.0×	163 1.1×	43	1.5k
Sudeep Karve United States	20	106 0.3×	125 0.6×	243 1.3×	321 1.7×	203 1.4×	63	1.5k
Panayotis Constantinou France	9	108 0.3×	134 0.6×	101 0.5×	202 1.1×	91 0.6×	25	781
Elena Schievano Italy	15	166 0.5×	280 1.3×	67 0.3×	335 1.8×	84 0.6×	49	931
Ji Young Lee United States	19	275 0.8×	410 1.9×	88 0.5×	142 0.8×	164 1.1×	68	1.3k
Wing C. Chan Canada	18	156 0.5×	124 0.6×	61 0.3×	115 0.6×	161 1.1×	78	1.1k

Countries citing papers authored by Katherine E. Mues

Since Specialization

Citations

This map shows the geographic impact of Katherine E. Mues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Mues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Mues more than expected).

Fields of papers citing papers by Katherine E. Mues

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Mues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Mues. The network helps show where Katherine E. Mues may publish in the future.

Co-authorship network of co-authors of Katherine E. Mues

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Mues. A scholar is included among the top collaborators of Katherine E. Mues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Mues. Katherine E. Mues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beck, Ekkehard, Elisha Beebe, Daina B. Esposito, et al.. (2024). Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States. Infectious Diseases and Therapy. 14(1). 199–216. 5 indexed citations

Ben‐Joseph, Rami, Virend K. Somers, Jed Black, et al.. (2024). Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study. Mayo Clinic Proceedings. 99(11). 1710–1721. 5 indexed citations

Bush, Christopher, Katherine E. Mues, Ekkehard Beck, et al.. (2024). Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States. Vaccine. 42(25). 126113–126113. 4 indexed citations

Li, Linwei, et al.. (2024). Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults. Infectious Diseases and Therapy. 13(8). 1771–1787. 3 indexed citations

Jain, Purva, et al.. (2023). Testing for Cytomegalovirus Among Individuals Who Were Immunocompromised, 2018-2022. JAMA Network Open. 6(11). e2345126–e2345126. 1 indexed citations

McKinley, Emily, Lisandro D. Colantonio, Robert S. Rosenson, et al.. (2022). Characteristics of patients with diabetes and a history of myocardial infarction initiating PCSK9 and SGLT2 inhibitors. SHILAP Revista de lepidopterología. 13. 100121–100121. 1 indexed citations

Arnold, Suzanne V., Christopher P. Cannon, James A. de Lemos, et al.. (2021). What Do US Physicians and Patients Think About Lipid‐Lowering Therapy and Goals of Treatment? Results From the GOULD Registry. Journal of the American Heart Association. 10(16). e020893–e020893. 14 indexed citations

Bress, Adam P., Catherine G. Derington, Jordan B. King, et al.. (2021). Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction. Journal of clinical lipidology. 15(5). 665–673. 18 indexed citations

Hess, Connie N., Christopher P. Cannon, Joshua A. Beckman, et al.. (2021). Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology. 77(24). 3016–3027. 18 indexed citations

10.

Muntner, Paul, Kate K. Orroth, Katherine E. Mues, et al.. (2021). Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease. Cardiovascular Drugs and Therapy. 36(3). 475–481. 9 indexed citations

11.

Cannon, Christopher P., James A. de Lemos, Robert S. Rosenson, et al.. (2019). Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States. American Heart Journal. 219. 70–77. 16 indexed citations

12.

Cannon, Christopher P., James A. de Lemos, Robert S. Rosenson, et al.. (2018). GETTING TO AN IMPROVED UNDERSTANDING OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND DYSLIPIDEMIA MANAGEMENT (GOULD): A REGISTRY OF HIGH CARDIOVASCULAR RISK PATIENTS IN THE UNITED STATES. Journal of the American College of Cardiology. 71(11). A1767–A1767. 1 indexed citations

13.

Mues, Katherine E., Patrick J. Lammie, Mitchel Klein, et al.. (2015). Changes in Antibody Levels during and following an Episode of Acute Adenolymphangitis (ADL) among Lymphedema Patients in Léogâne, Haiti. PLoS ONE. 10(10). e0141047–e0141047. 4 indexed citations

14.

Rebolledo, Paulina A., et al.. (2014). Evaluation of a Residential Nutrition Rehabilitation Center in Rural Bolivia: Short-Term Effectiveness and Follow-Up Results. Food and Nutrition Bulletin. 35(2). 211–220.

15.

Perez, Lilian G., et al.. (2013). Satisfacao dos profissionais e da comunidade com a estrategia da saude da familia. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 1 indexed citations

16.

Mues, Katherine E., Douglas H. Esposito, Pauline Han, et al.. (2013). Analyzing GeoSentinel Surveillance Data: A Comparison of Methods to Explore Acute Gastrointestinal Illness Among International Travelers. Clinical Infectious Diseases. 58(4). 546–554. 4 indexed citations

17.

Budge, Philip J., et al.. (2013). Impact of Community-Based Lymphedema Management on Perceived Disability among Patients with Lymphatic Filariasis in Orissa State, India. PLoS neglected tropical diseases. 7(3). e2100–e2100. 33 indexed citations

18.

Mues, Katherine E., et al.. (2012). User satisfaction with the Family Health Program in Vespasiano, Minas Gerais, Brazil. Revista Panamericana de Salud Pública. 31(6). 454–460. 8 indexed citations

19.

Jentes, Emily S., Xiaohong M. Davis, Victor Balaban, et al.. (2010). Health Risks and Travel Preparation Among Foreign Visitors and Expatriates During the 2008 Beijing Olympic and Paralympic Games. American Journal of Tropical Medicine and Hygiene. 82(3). 466–472. 7 indexed citations

20.

Johnson, Crista, et al.. (2008). Cervical Cancer Screening Among Immigrants and Ethnic Minorities. Journal of Lower Genital Tract Disease. 12(3). 232–241. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact